It is interesting to note that CD36-expressing leukemic stem cells (LSCs) in BP-CML have been shown to confer protective effect from anticancer therapies by the accumulation of lipid droplets [24, 25]. Here, CD36 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.